SEC EDGAR · company profile · free

CVS HEALTH Corp due diligence

Who CVS HEALTH Corp (CVS) is on the public record: identity, annual results, what it filed in the last year and why, straight from SEC EDGAR.

1000 filings in EDGAR's recent index, 520 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index and XBRL financial data

At a glance

CVS HEALTH Corp (CVS) is a large accelerated filer incorporated in Delaware, classified under SIC 5912 (Retail-Drug Stores and Proprietary Stores), and lists on NYSE. Its fiscal year ends December 31. It has also filed as CVS CAREMARK CORP, CVS/CAREMARK CORP, and CVS CORP.

For the fiscal year ended December 31, 2025, its 10-K reported revenue of $402B, up 7.8% from the year before, net income of $1.8B, and total assets of $254B.

In the twelve months to October 9, 2026 it made 80 filings on EDGAR, including 1 annual report, 3 quarterly reports, 9 current reports on Form 8-K, and 48 Form 4 insider filings. Its 8-Ks were filed most often for results of operations (4), officer or director changes (3), and Regulation FD disclosures (2).

CIK
0000064803
Filer status
Large accelerated filer
Industry (SIC)
Retail-Drug Stores and Proprietary Stores (5912)
Incorporated
Delaware
Listed on
NYSE
Tickers
CVS
Fiscal year end
12-31

Annual results

Fiscal year endedRevenueNet incomeTotal assets
2025-12-31$402B +7.8%$1.8B -61.7%$254B
2024-12-31$373B +4.2%$4.6B -44.7%$253B
2023-12-31$358B$8.3B$250B
As reported in each 10-K's XBRL data on SEC EDGAR (revenue tag Revenues); a later 10-K's restatement replaces the earlier figure.
FilingFiledPeriodAccession
Annual report (10-K)2026-02-102025-12-310000064803-26-000010
Quarterly report (10-Q)2026-08-052026-06-300000064803-26-000098
Current report (8-K)2026-08-172026-08-130001193125-26-354096

Filing activity

80 filings since 2025-10-09. By form:

4
48
8-K
9
13F-HR
4
10-Q
3
144
3
3/A
2
SCHEDULE 13G/A
2
10-K
1

8-K items in the last 12 months: results of operations (Item 2.02, 4) · officer or director changes (Item 5.02, 3) · Regulation FD disclosures (Item 7.01, 2) · shareholder vote results (Item 5.07, 1) · other events (Item 8.01, 1).

FiledFormDocumentPeriod
2026-08-178-K8-K2026-08-13
2026-08-13SCHEDULE 13G/ASchedule 13G amendment
2026-08-0613F-HRForm 13F-HR filing2026-06-30
2026-08-0510-Q10-Q2026-06-30
2026-08-058-K8-K2026-08-05
2026-06-294PRIMARY DOCUMENT2026-06-26
2026-06-2311-K11-K2025-12-31
2026-06-014PRIMARY DOCUMENT2026-05-31
2026-06-014PRIMARY DOCUMENT2026-05-31
2026-05-224PRIMARY DOCUMENT2026-05-20
free alert

Free. One email a day at most, only when something changes. Confirm by email first; unsubscribe with one click. Privacy.

The full due-diligence dossier on CVS HEALTH Corp

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"CVS"} over x402 or MPP, $0.85

Sample output and API docs · all reports

CVS insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.